352
Views
6
CrossRef citations to date
0
Altmetric
Review

Nanocarriers-loaded with natural actives as newer therapeutic interventions for treatment of hepatocellular carcinoma

ORCID Icon, , , , , , , , , , , ORCID Icon & show all
Pages 489-513 | Received 22 Mar 2020, Accepted 18 Nov 2020, Published online: 20 Jan 2021

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (1)

Zachary J. Brown, D. Brock Hewitt & Timothy M. Pawlik. (2022) Experimental drug treatments for hepatocellular carcinoma: clinical trial failures 2015 to 2021. Expert Opinion on Investigational Drugs 31:7, pages 693-706.
Read now

Articles from other publishers (5)

Aditya Singh, Shubhrat Maheshwari, Vishal Kumar Vishwakarma & Saad Mohammed. (2023) Processed excipients for targeted drug delivery in cancer management: Enhancing efficacy and precision. Intelligent Pharmacy.
Crossref
Xu-Wang Pan, Jin-Song Huang, Shou-Rong Liu, Yi-Dan Shao, Jian-Jun Xi, Ruo-Yu He, Ting-Ting Shi, Rang-Xiao Zhuang & Jian-Feng Bao. (2023) Evaluation of the liver targeting and anti‑liver cancer activity of artesunate‑loaded and glycyrrhetinic acid‑coated nanoparticles. Experimental and Therapeutic Medicine 26:5.
Crossref
Mengjiao Xu, Liu Yang, Yanjie Lin, Yao Lu, Xiaoyue Bi, Tingting Jiang, Wen Deng, Lu Zhang, Wei Yi, Yao Xie & Minghui Li. (2022) Emerging nanobiotechnology for precise theranostics of hepatocellular carcinoma. Journal of Nanobiotechnology 20:1.
Crossref
Ning Li, Xiaoyu Zhang, Jin Zhou, Wang Li, Xinyu Shu, Yi Wu & Mian Long. (2022) Multiscale biomechanics and mechanotransduction from liver fibrosis to cancer. Advanced Drug Delivery Reviews 188, pages 114448.
Crossref
Mohammad Javed Ansari, Mahfoozur Rahman, Khalid S. Alharbi, Waleed M. Altowayan, Ahmed Mahmoud Abdelhaleem Ali, Waleed H. Almalki, Md. Abul Barkat, Tanuja Singh, Shehla Nasar, Md Habban Akhter, Sarwar Beg & Hani Choudhry. (2022) Hispolon-Loaded Liquid Crystalline Nanoparticles: Development, Stability, In Vitro Delivery Profile, and Assessment of Hepatoprotective Activity in Hepatocellular Carcinoma. ACS Omega 7:11, pages 9452-9464.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.